Introduction {#s1}
============

One of the prerequisites for the success of primary health care is the availability and use of suitable drugs. Traditional medicine is still the most affordable and easily accessible source of treatment in the primary healthcare system. Medicinal plants have always been a potential source to cure different diseases, either in the form of traditional preparations or as pure active principles, and they are frequently the only source of medicine for the majority of people in the developing world.

*Swertia*, a genus in the family Gentianaceae include a large group of annual and perennial herbs, representing approximately 135 species. *Swertia* species are common ingredients in a number of herbal remedies. In India, 40 species of *Swertia* are recorded (Clarke, [@B36]; Kirtikar and Basu, [@B64]), of which, *Swertia chirayita* is considered the most important for its medicinal properties. *S. chirayita* was first described by Roxburgh under the name of *Gentiana chyrayta* in 1814 (Scartezzini and Speroni, [@B110]). *S. chirayita*, common name: "Chiretta" (Figure [1](#F1){ref-type="fig"}) is a critically endangered medicinal herb that grows at high altitudes in the sub-temperate regions of the Himalayas between 1200 and 2100 m altitudes from Kashmir to Bhutan (Bentley and Trimen, [@B19]; Clarke, [@B36]) on the slopes of moist shady places (Gaur, [@B44]; Figure [2](#F2){ref-type="fig"}). Its widespread uses in traditional medicine have resulted in over-exploitation from the natural habitat and it is now on the verge of extinction in the wild. *S. chirayita* is also known by an array of names such as Anaryatikta, Bhunimba, Chiratitka, Kairata in Sanskrit, Qasabuzzarirah in Arab and Farsi, Chiaravata in Urdu, Sekhagi in Burma, and Chirrato or Chiraita in Nepal (Joshi and Dhawan, [@B56]). Some authors have described *S. chirayita* as an annual (Anon, [@B6]; Kirtikar and Basu, [@B64]) and others as a biennial or pluri-annual (Edwards, [@B39]). This ethnomedicinal herb is known mostly for its bitter taste caused by the presence of different chemical constituents such as amarogentin (most bitter compound isolated till date), swerchirin, swertiamarin, and other bioactive compounds that are directly associated with human health welfare (Joshi and Dhawan, [@B56]). Due to its excessive over-exploitation from the natural habitat, narrow geographic occurrence (Bhat et al., [@B21]) and unresolved inherent problems of seed viability and seed germination (Badola and Pal, [@B12]; Joshi and Dhawan, [@B56]), alternative approaches for propagation and conservation are urgently required to avoid the possible extinction of this important species. Consequently, *S. chirayita* has been receiving increasing attention from a wide range of researchers as evident from the number of publications appearing in the literature (Chen et al., [@B35]; Nagalekshmi et al., [@B87]; Ghosh et al., [@B46]; Kumar and Chandra, [@B69], [@B70], [@B71]; Fan et al., [@B41]; Kumar et al., [@B73]; Sharma et al., [@B116], [@B117]; Padhan et al., [@B91]; Zhou et al., [@B136]). However, a comprehensive review detailing the documented ethnomedicinal uses, pharmacological properties and safety evaluation carried out on *S. chirayita* and identifying the existing knowledge gap is lacking. In this review, we document the medicinal uses and phytochemical properties of *S. chirayita*. Future prospects including the potential conservation approaches to ensure a continuous supply for both local and international expanding markets and safety evaluation on uses of the species for medicinal purposes are highlighted.

![***Swertia chirayita.* (A)** Seeds, **(B)** Plant in nature, **(C)** Root of a mature plant, **(D)** Dry plant material, **(E)** High shoot multiplication in a plant tissue culture system.](fphar-06-00308-g0001){#F1}

![**Natural distribution of *Swertia chirayita.*** The shaded area represents the natural habitat of *Swertia chirayita* in the Himalayan Region.](fphar-06-00308-g0002){#F2}

Botanical description
---------------------

*S. chirayita* is an annual/biennial herb 0.6--1.5 m tall. It has an erect, around 2--3 ft long stem, the middle portion is cylindrical, while the upper is quadrangular, with a prominent decurrent line at each angle. Its stem is orange brown or purplish in color with large continuous yellowish pith (Bentley and Trimen, [@B19]; Joshi and Dhawan, [@B56]). Leaves are lanceolate, in opposite pairs, no stalks, acuminate, cordate at the base, sessile, five to seven nerved and 4 cm long (Scartezzini and Speroni, [@B110]). The root is simple, yellowish, somewhat oblique, or geniculate, tapering and short, almost 7--8 cm long and usually half an inch thick (Bentley and Trimen, [@B19]; Scartezzini and Speroni, [@B110]). Flowers are small, numerous, tetramerous, large leafy panicles, green-yellow, and tinged with purple and green or white hairs (Scartezzini and Speroni, [@B110]; Joshi and Dhawan, [@B56]). The calyx is gamophyllous with four lobes, corolla-lobes four twisted and superimposed, united at the base where they have pairs of nectaries on each lobe covered with long hairs. Stamens 4, opposite the corolla lobe, at the base of the corolla. Ovary unilocular with ovules laminal placentation parietale; two stigmas. Capsules are egg-shaped, 2-valved with a transparent yellowish pericarp. Seeds are numerous, very small and dark brownish in color (Chandra et al., [@B29]). Multi-colored corolla and the presence of nectaries support cross-pollination in *S. chirayita*.

Medicinal uses {#s2}
==============

*S. chirayita* a traditional Ayurvedic herb is used by different indigenous population groups in multiple ways for several medicinal purposes (Table [1](#T1){ref-type="table"}). The whole plant is widely used by local people for the treatment of hepatitis, inflammation, and digestive diseases (Bhatt et al., [@B23]). The wide range of medicinal uses include the treatment of chronic fever, malaria, anemia, bronchial asthma, hepatotoxic disorders, liver disorders, hepatitis, gastritis, constipation, dyspepsia, skin diseases, worms, epilepsy, ulcers, scanty urine, hypertension, melancholia, and certain types of mental disorders, secretion of bile, blood purification, and diabetes (Karan et al., [@B59]; Banerjee et al., [@B17]; Rai et al., [@B100]; Saha et al., [@B103]; Chen et al., [@B35]). Recently, *S. chirayita* extracts showed anti-hepatitis B virus (anti-HBV) activities (Zhou et al., [@B136]). Traditionally, decoctions of this species are used for anthelmintic, hepatoprotective, hypoglycemic, antimalarial, antifungal, antibacterial, cardiostimulant, antifatigue, anti-inflammatory, antiaging, antidiarrheal, as protectant of the heart and also help in lowering blood pressure and blood sugar (Schimmer and Mauthner, [@B111]). Herbal formulations such as Ayush-64, Diabecon, Mensturyl syrup, and Melicon V ointment (Edwin and Chungath, [@B40]; Mitra et al., [@B84]) contain *S. chirayita* extract in different concentrations for its antipyretic, hypoglycaemic, antifungal, and antibacterial properties. Furthermore, the curative value of this herb has also been recorded in ancient Ayurveda medicine systems and other conventional medical systems.

###### 

**Ethnobotanical uses of *Swertia chirayita* in traditional medicine**.

  **Plant part used**   **Traditional uses**                                                                                                                                                                                                                                                                                                                                                          **References**
  --------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------
  Whole plant           Used in several traditional and indigenous systems of medicines, such as Ayurveda, Unani, and Siddha                                                                                                                                                                                                                                                                          Mukherji, [@B85]; Kirtikar and Basu, [@B64]; Joshi and Dhawan, [@B56];
  Whole plant           Used in British and American pharmacopeias as tinctures and infusions                                                                                                                                                                                                                                                                                                         Joshi and Dhawan, [@B56]
  Root                  Serves as a drug and an effective tonic for general weakness, fever, cough, joint pain, asthma, and the common cold                                                                                                                                                                                                                                                           Kirtikar and Basu, [@B64]; Joshi and Dhawan, [@B56]
  Whole plant           For headaches and blood pressure, the leaves and chopped stems are soaked overnight in water. A paste is prepared and filtered with 1 glass of water. The preparation is consumed once a day for 2--3 days                                                                                                                                                                    de Rus Jacquet et al., [@B38]; Malla et al., [@B79]
  Whole plant           For Tremor fever, whole *S. chirayita* plants are cut into small pieces and boiled in 1/2 L of water until the volume is reduced to less than half glass. The filtered water is stored in a glass bottle and half spoon is given to children once a day for 2 days. For adult, the posology is 1 spoon once in a day for 2 days and varies to three times a day until cured   de Rus Jacquet et al., [@B38]
  Whole plant           Boiled in water and one cup of decoction is taken orally to cure malaria                                                                                                                                                                                                                                                                                                      Shah et al., [@B113]
  Whole plant           Paste of the plant is applied to treat skin diseases such as eczema and pimples                                                                                                                                                                                                                                                                                               Joshi and Dhawan, [@B56]; Malla et al., [@B79]
  Whole plant           Liver disorders; stomach disorders like dyspepsia and diarrhea, intestinal worms                                                                                                                                                                                                                                                                                              Mukherji, [@B85]; Joshi and Dhawan, [@B56]
  Whole plant           Hiccups and vomiting, ulcers, gastrointestinal infections, and kidney diseases                                                                                                                                                                                                                                                                                                Kirtikar and Basu, [@B64]
  Whole plant           Used in combination with other drugs in cases of scorpion bite                                                                                                                                                                                                                                                                                                                Nandkarni, [@B88]
  Whole plant           Used in excessive vaginal discharge                                                                                                                                                                                                                                                                                                                                           Jadhav and Bhutani, [@B53]

The widespread uses of *S. chirayita* in traditional drugs have resulted in considerable chemical analysis of the plant, and active principles which attribute the plant its medicinal properties. *S. chirayita* is also used in British and American pharmacopeias as tinctures and infusions (Joshi and Dhawan, [@B56]). The whole plant is used in traditional remedies but the root is mentioned to be the most bioactive part (Kirtikar and Basu, [@B64]).

Pharmacological activity {#s3}
========================

The varied ethnobotanical uses of *S. chirayita* have led to the initiation of various pharmacological investigations. Previous research demonstrates that the *S. chirayita* extracts exhibit a wide range of biological activities, such as antibacterial, antifungal, antiviral, anticancer, anti-inflammatory, and others like antidiabetic and antioxidant activities (Verma et al., [@B127]; Alam et al., [@B5]; Arya et al., [@B9]; Chen et al., [@B35]; Laxmi et al., [@B75]). Concurrently, a diverse range of *in vitro* and *in vivo* test systems has been used to evaluate the pharmacological properties of *S. chirayita*. Evidence-based laboratory investigations indicate that aqueous, alcoholic and methanolic extracts of *S. chirayita* possess a number of promising pharmacological properties. The whole plant of *S. chirayita* have been reported to be used for the treatment of antibacterial and antifungal activity (Alam et al., [@B5]; Laxmi et al., [@B75]; Rehman et al., [@B102]). Anti-hepatitis B virus activity of *S. chirayita* extracts was also studied on HepG 2.2.15 cells line (Zhou et al., [@B136]). The whole plant of *S. chirayita* has been reported for the anti-inflammatory and hypoglycemic activity (Banerjee et al., [@B17]; Kar et al., [@B58]; Alam et al., [@B3]; Das et al., [@B37]; Verma et al., [@B128]). Chen et al. ([@B35]) investigated the 70% ethanolic extract of *S. chirayita* for antioxidant activities by using antioxidant tests including reducing power and beta-carotene assay. The results showed that 70% ethanolic extracts exhibited high DPPH scavenging activity (IC~50~ = 267.80 μg/mL). Table [2](#T2){ref-type="table"} presents a summary focusing on the pharmacological evaluations using *in vitro* and *in vivo* systems whereas Table [3](#T3){ref-type="table"} provides antioxidant potential of *S. chirayita*.

###### 

**Evaluation of the biological activities of *Swertia chirayita***.

  **Bioactivity evaluated**         **Plant part(s) tested**   **Test system**   **[^a^](#TN1){ref-type="table-fn"}Extracting solvent**   **Test Organism/Models**                                                             **Control**                                                                                                            **Toxicity test**              **References**
  --------------------------------- -------------------------- ----------------- -------------------------------------------------------- ------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------- ------------------------------ -----------------------------
  Antibacterial                     Whole plant                *In vitro*        EtOH                                                     *Escherichia coli* ATCC 26922                                                        Ciprofloxacin                                                                                                          None                           Rehman et al., [@B102]
                                                                                                                                          *Klebsiella pneumonia* ATCC 15380                                                                                                                                                                                                          
                                                                                                                                          *Pseudomonas aeruginosa* ATCC 25619                                                                                                                                                                                                        
                                                                                                                                          *Proteus vulgaris* ATCC 6380                                                                                                                                                                                                               
  Antibacterial                     Stem                       *In vitro*        MeOH                                                     *Bacillus subtilis* ATCC 6633                                                        Ceftriaxone, Ceftriaxone sodium, Cefuroxine, Ciprofloxacin, Gentamycine, Levofloxacin, Metronidazole, Tranexamicacid   None                           Khalid et al., [@B63]
                                                                                                                                          *Enterococcus faecalis* (ATCC 14506)                                                                                                                                                                                                       
                                                                                                                                          *Staphylococcus aureus* (ATCC 6538)                                                                                                                                                                                                        
                                                                                                                                          *Pseudomonas aeruginosa* (ATCC 27853)                                                                                                                                                                                                      
                                                                                                                                          *Salmonella typhi* (ATCC 14028)                                                                                                                                                                                                            
  Antibacterial                     Whole plant                *In vitro*        MeOH                                                     *Bacillus subtilis* MTCC 736                                                         Gentamycin                                                                                                             None                           Laxmi et al., [@B75]
                                                                                                                                          *Bacillus polymyxa*                                                                                                                                                                                                                        
                                                                                                                                          *Staphylococcus aureus* MTCC 3160                                                                                                                                                                                                          
                                                                                                                                          *Escherichia coli* MTCC 723                                                                                                                                                                                                                
                                                                                                                                          *Salmonella typhi* MTCC 3216                                                                                                                                                                                                               
                                                                                                                                          *Vibria cholera* MTCC 3906                                                                                                                                                                                                                 
                                                                                                                                          *Streptococcus pyogenes* MTCC 1927                                                                                                                                                                                                         
                                                                                                                                          *Proteus mirabilis* MTCC 1429                                                                                                                                                                                                              
                                                                                                                                          *Providentia alkalifaciens*                                                                                                                                                                                                                
                                                                                                                                          *Pseudomonas aeruginosa* MTCC 7837                                                                                                                                                                                                         
  Antibacterial                     Whole plant                *In vitro*        DCM; EtOH                                                *Staphylococcus aureus*                                                              Kanamycin 30 μg/disc                                                                                                   None                           Alam et al., [@B5]
  Antibacterial                     Stem                       *In vitro*        EtOH                                                     *Staphylococcus aureus*                                                              Chloramphenicol 30 μg/disc                                                                                             Brine shrimp assay--positive   Sultana et al., [@B120]
                                                                                                                                          *Bacillus subtilis*                                                                                                                                                                                                                        
                                                                                                                                          *Salmonella typhi*                                                                                                                                                                                                                         
                                                                                                                                          *Shigella flexeneriae*                                                                                                                                                                                                                     
                                                                                                                                          *Sarcina lutea*                                                                                                                                                                                                                            
                                                                                                                                          *Bacillus megaterium*                                                                                                                                                                                                                      
  Antifungal                        Whole plant                *In vitro*        MeOH                                                     *Aspegillus niger* MTCC 1881                                                         Amphotericin                                                                                                           None                           Laxmi et al., [@B75]
                                                                                                                                          *Aspergillus flavus* MTCC 1883                                                                                                                                                                                                             
                                                                                                                                          *Cladosporium oxysporum* MTCC 1777                                                                                                                                                                                                         
  Antileishmanial                   Aerial part                *In vitro*        95% EtOH                                                 *Leishmania donovani UR6*                                                            --                                                                                                                     None                           Ray et al., [@B101]
  Antileishmanial                   Whole plant                *In vitro*        MeOH                                                     *Leishmania donovani AG83*                                                           --                                                                                                                     Cytotoxicity test-negative     Medda et al., [@B83]
  Antihelmintic                     Whole plant                *In vitro*        Water; MeOH                                              *Haemonchus contortus*                                                               Levamisole 0.55 mg/ml                                                                                                  None                           Iqbal et al., [@B52]
  Antimalarial                      Leaves/Stem                *In vitro*        MeOH; PE; Water; EtOH                                    *Plasmodium falciparum* FCK 2                                                        Parasitized red blood cells and 10 μCi of \[^35^S\]-methionine                                                         None                           Bhat and Surolia, [@B22]
  Egg hatchability and larvicidal   Whole plant                *In vitro*        HEX; EA; MeOH                                            *Aedes aegypti*                                                                      Tween-80                                                                                                               None                           Balaraju et al., [@B15]
                                                                                                                                          *Culex quinquefasciatus*                                                                                                                                                                                                                   
  Anti-hepatitis B virus            Whole plant                *In vitro*        50% EtOH                                                 HepG 2.2.15 cells line                                                               Tenofovir                                                                                                              None                           Zhou et al., [@B136]
  Antiinflammatory                  Aerial parts               *In vivo*         Petroleum                                                N/A                                                                                  Mice treated with vehicle or Diclofenac (10 mg/kg)                                                                     None                           Banerjee et al., [@B17]
  Antiinflammatory                  Root                       *In vivo*         95% EtOH                                                 N/A                                                                                  Diclofenac (25 mg/kg)                                                                                                  None                           Das et al., [@B37]
  Hypoglycemic                      Whole plant                *In vivo*         95% EtOH                                                 N/A                                                                                  Mice treated with vehicle                                                                                              None                           Kar et al., [@B58]
  Hypoglycemic                      Leaves                     *In vivo*         EtOH                                                     N/A                                                                                  Glibenclamide (5 mg/kg)                                                                                                None                           Alam et al., [@B3]
  Hypoglycemic                      Whole plant                *In vivo*         EA; EtOH                                                 N/A                                                                                  Glibenclamide (5 mg/kg)                                                                                                Cytotoxicity test-negative     Verma et al., [@B128]
  Antidiabetic                      Whole plant                *In vitro*        95% EtOH; HEX                                            STZ-NAD(streptozotocin- nicotinamide) induced diabetic albino mice                   Metformin (100 μg/kg)                                                                                                  None                           Grover et al., [@B47]
  Antidiabetic                      Whole plant                *In vitro*        EtOH; HEX; Chloroform                                    STZ-NAD(streptozotocin- nicotinamide) induced diabetic albino mice                   Metformin (100 μg/kg)                                                                                                  None                           Arya et al., [@B9]
  Antipyretic                       Root                       *In vitro*        Water                                                    Brewer\'s yeast induced pyrexia Typhoid-Paratyphoid A, B vaccine induced Hyperexia   Paracetamol (150 mg kg^−1^)                                                                                            None                           Bhargava et al., [@B20]
  Anticarcinogenic                  Whole plant                *In vivo*         HEX                                                      N/A                                                                                  9,10-dimethyl benz(a)anthracene (DMBA)                                                                                 None                           Saha et al., [@B103]
  Analgesic                         Leaves/Stem                *In vivo*         EtOH                                                     N/A                                                                                  Diclofenac sodium (25 mg/kg)                                                                                           None                           Alam et al., [@B4]
  Analgesic                         Root                       *In vivo*         EtOH                                                     N/A                                                                                  Aminopyrine (50 mg/kg)                                                                                                 None                           Das et al., [@B37]
  Hepatoprotective                  Aerial parts               *In vivo*         70% EtOH                                                 N/A                                                                                  Paracetamol (150 mg/kg)                                                                                                None                           Nagalekshmi et al., [@B87]
  CNS                               Whole plant                *In vivo*         EtOH                                                     N/A                                                                                  Mice treated with vehicle                                                                                              None                           Bhattacharya et al., [@B25]
  Antiviral                         Leaves/Stem                *In vitro*        Water                                                    Herpes simplex virus type-1                                                          Acyclovir (1 mg/mL)                                                                                                    Cytotoxicity test-negative     Verma et al., [@B127]

Extracting solvent: EtOH, ethanol; EA, ethyl acetate; HEX, hexane; MeOH, methanol; N/A, not applicable; PE, petroleum ether.

###### 

**Antioxidant potential of different solvent extracts of *S. chirayita***.

  **Plant part tested**   **[^a^](#TN2){ref-type="table-fn"}Extracting solvent**   **Test system**   **Control used and result**                                             **Toxicity test**            **References**
  ----------------------- -------------------------------------------------------- ----------------- ----------------------------------------------------------------------- ---------------------------- ---------------------------
  Whole plant             70% EtOH                                                 *In vitro*        BHT and Vitamin C                                                       None                         Chen et al., [@B35]
                                                                                                     IC~50~ = 267.80 μg/mL (DPPH)                                                                         
                                                                                                     IC~50~ = 1.502 ± 0.200 μg/mL (β-carotene)                                                            
                                                                                                     IC~50~ = 6.50 μg/mL (ABTS)                                                                           
  Whole plant             70% EtOH                                                 *In vivo*         NA                                                                      Cytotoxicity test-negative   Chen et al., [@B35]
  Whole plant             MeOH                                                     *In vitro*        BHT                                                                     None                         Sharma et al., [@B115]
                                                                                                     EC~50~ = 27.70 μg/ml (DPPH)                                                                          
  Whole plant             MeOH                                                     *In vitro*        BHA                                                                     None                         Ahirwal et al., [@B1]
                                                                                                     IC~50~ = 222.74 μg/mL (DPPH)                                                                         
  Whole plant             Water                                                    *In vitro*        Gallic acid                                                             None                         Kumar et al., [@B72]
                                                                                                     EC~50~ = 315.83 μg/mL (DPPH)                                                                         
  Leaves                  Water                                                    *In vitro*        BHA; BHT                                                                None                         Ghosh et al., [@B46]
                                                                                                     IC~50~ = 86 μg/mL (DPPH)                                                                             
                                                                                                     900 ± 11(4 min) and 2070 ± 110 (30 min) μM Fe (II)/g sample DW (FRAP)                                
  Whole plant             12% EtOH                                                 *In vitro*        Ascorbic acid                                                           None                         Phoboo et al., [@B99]
                                                                                                     IC~50~ = 156.62 μg/mL (DPPH)                                                                         
  Whole plant                                                                      *In vitro*        Gallic acid                                                             None                         Kshirsagar et al., [@B67]
                          MeOH                                                                       IC~50~ = 551.26 μg/mL (DPPH)                                                                         
                          EtOH                                                                       IC~50~ = 557.61 μg/mL (DPPH)                                                                         
                          ACE                                                                        IC~50~ = 551.96 μg/mL (DPPH)                                                                         
                          Water                                                                      IC~50~ = 559.05 μg/mL (DPPH)                                                                         

ABTS, 2,2-azino-bis (3-ethylebenzthiazoline-6-sulphonicacid); BHA, Butylated hydroxy anisole; BHT, Butylated hydroxytoluene; DPPH, 2,2-Diphenyl-1-picrylhdrazyl; DW, Dry weight; FRAP, Ferric Reducing Antioxidant Power

Extracting solvent: ACE, acetone; EtOH, ethanol; MeOH, methanol

Phytochemistry {#s4}
==============

The widespread uses of *S. chirayita* as a traditional drug and its commercialization in modern medical systems have led to a rise in scientific exploration of its phytochemistry in order to identify the active phytochemicals. This has resulted in a considerable body of literature exploring the chemical constituents of this plant (Mandal and Chatterjee, [@B80]; Chakravarty et al., [@B27], [@B28]; Mandal et al., [@B82]; Chatterjee and Pakrashi, [@B31]; Pant et al., [@B95]). The wide-range biological activities of *S. chirayita* are attributed to the presence of a diverse group of pharmacologically bioactive compounds belonging to different classes such as xanthones and their derivatives, lignans, alkaloids, flavonoids, terpenoids, iridoids, secoiridoids, and other compounds such as chiratin, ophelicacid, palmitic acid, oleic acid, and stearic acid (Pant et al., [@B95]; Patil et al., [@B97]). The first isolated dimeric xanthone was chiratanin present in different parts of *S. chirayita*. The pharmacological efficacy of *S. chirayita* has been partly attributed to the biological activity of major phytoconstituents including amarogentin, swertiamarin, mangiferin, swerchirin, sweroside, amaroswerin, and gentiopicrin (Figure [3](#F3){ref-type="fig"}). Amarogentin is reported to be anti-diabetic (Phoboo et al., [@B99]), anticancerous (Saha et al., [@B104]; Pal et al., [@B92]), and antileishmanial (Ray et al., [@B101]; Medda et al., [@B83]), whereas swertiamarin has been tested for its anti-hepatitis (Wang et al., [@B130]), anticancer (Kavimani and Manisenthlkumar, [@B60]), anti-arthritic activities (Saravanan et al., [@B106]). It has been shown to exhibit anti-diabetic (Vaidya et al., [@B124]) properties. Mangiferin is also reported to have anti-diabetic, antiatherosclerotic (Pardo-Andreu et al., [@B96]), anticancer, anti-HIV (Guha et al., [@B48]), antiparkinson (Kavitha et al., [@B61]), and chemopreventive (Yoshimi et al., [@B134]) activities. Swerchirin is known to be antimalarial, hypoglycemic (Bajpai et al., [@B13]; Saxena et al., [@B109]), hepatoprotective, pro-heamatopoietic (Ya et al., [@B133]), with blood glucose lowering activity (Sekar et al., [@B112]; Saxena et al., [@B107]) and weak chemo preventive pharmacological effects (Hirakawa et al., [@B50]). Swerchirin at different concentrations (1, 10, and 100 μM) significantly enhanced glucose stimulated insulin release from isolated islets (Saxena et al., [@B108]). Sweroside is reported to be antibacterial (Siler et al., [@B118]), hepatoprotective (Liu et al., [@B77]; Luo et al., [@B78]), preventative in treatment for hyperpigmentation (Jeong et al., [@B54]), and is also suggested as a promising osteoporosis therapeutic natural product (Sun et al., [@B121]). Amaroswerin is known for its gastroprotective effects of the bitter principles (Niiho et al., [@B90]). Table [4](#T4){ref-type="table"} provides a summary focusing on the biological activity of the phytochemicals present in *S. chirayita*.

![**Chemical structures of important phytoconstituents found in *Swertia chirayita***.](fphar-06-00308-g0003){#F3}

###### 

**Important bioactive compounds isolated from *Swertia chirayita***.

  **Phytochemical**                    **Biological activity**                   **References**
  ------------------------------------ ----------------------------------------- --------------------------------------------------
  Amarogentin                          Antileishmanial                           Ray et al., [@B101]; Medda et al., [@B83]
                                       Topoisomerase inhibitor                   Ray et al., [@B101]
                                       Anticancer                                Saha et al., [@B104]; Pal et al., [@B92]
                                       Anti-diabetic                             Phoboo et al., [@B99]
                                       Gastroprotective                          Niiho et al., [@B90]
  Swertiamarin                         CNS depressant                            Bhattacharya et al., [@B25]
                                       Anticholinergic                           Suparna et al., [@B122]
                                       Anticancer                                Kavimani and Manisenthlkumar, [@B60]
                                       Anti-hepatitis                            Wang et al., [@B130]
                                       Antibacterial                             Kumarasamy et al., [@B74]
                                       Cardio-protective, anti-atherosclerotic   Vaidya et al., [@B125]
                                       anti-diabetic                             Vaidya et al., [@B124]
                                       Anti-arthritic                            Saravanan et al., [@B106]
  Mangiferin                           Antiviral                                 Zheng and Lu, [@B135]
                                       Immunomodulatory, antitumor, anti-HIV     Guha et al., [@B48]
                                       Antioxidant                               Sanchez et al., [@B105]
                                       Chemopreventive                           Yoshimi et al., [@B134]
                                       Antiinflammatory                          Kumar et al., [@B68]
                                       Hypoglycemic                              Muruganandan et al., [@B86]
                                       Anti-diabetic, Antiatherosclerotic        Pardo-Andreu et al., [@B96]
                                       Antiparkinson                             Kavitha et al., [@B61]
  Swerchirin                           Hypoglycemic                              Bajpai et al., [@B13]; Saxena et al., [@B109]
                                       Hepatoprotective, pro-heamatopoietic      Ya et al., [@B133]
                                       Blood glucose lowering activity           Sekar et al., [@B112]; Saxena et al., [@B108]
                                       Chemopreventive                           Hirakawa et al., [@B50]
  Sweroside                            Antibacterial                             Siler et al., [@B118]
                                       Hepatoprotective                          Liu et al., [@B77]; Luo et al., [@B78]
                                       Hyperpigmentation                         Jeong et al., [@B54]
                                       Osteoporosis                              Sun et al., [@B121]
  Amaroswerin                          Gastroprotective                          Niiho et al., [@B90]
  Gentianine                           Antipsychotic                             Bhattacharya et al., [@B24]
                                       Antimalarial                              Natarajan et al., [@B89]
  Oleanolic acid                       Antimicrobial                             Jesus et al., [@B55]
                                       Antitumor                                 Soica et al., [@B119]
                                       Antiinflamatory, antioxidant              Liu, [@B76]
  Ursolic acid                         Antimicrobial                             Jesus et al., [@B55]
                                       Antitumor                                 Bonaccorsi et al., [@B26]; Soica et al., [@B119]
  Swertanone                           Antiinflammatory                          Kumar et al., [@B68]; Tabassum et al., [@B123]
  Syringaresinol                       Hepatoprotective                          Chakravarty et al., [@B28]
  Bellidifolin                         Hypoglycemic                              Basnet et al., [@B18]
  Isobellidifolin                      Hypoglycemic                              Basnet et al., [@B18]
  1-Hydroxy-3,5,8-trimethoxyxanthone   Antimalarial                              Mandal and Chatterjee, [@B81]
  1-Hydroxy-3,7,8-trimethoxyxanthone   Spasmogenic agent                         Ateufack et al., [@B10]
                                       Antiulcerogenic                           Ateufack et al., [@B11]
  1,5,8-trihydroxy-3-methoxyxanthone   Blood sugar lowering                      Ghosal et al., [@B45]
  β-Amyrin                             Anti-inflammatory                         Holanda et al., [@B51]
                                       Antimicrobial, antifungal                 Vázquez et al., [@B126]
  Chiratol                             Anti-inflammatory                         Banerjee et al., [@B17]

Safety evaluation {#s5}
=================

Concerns regarding safety of conventional drugs are vital issues of pharmaceutical industries. Studies have indicated that some commonly used medicinal plants may be mutagenic or cytotoxic especially over a long period of use (Verschaeve and Van Staden, [@B129]). There is increasing evidence on the toxicity of crude extracts and isolated compounds from different plant species (Koorbanally et al., [@B65]). However, despite its long history of use in traditional medicine, there is still a lack of scientific information concerning the safety evaluation of *S. chirayita*. It can be traced through the medicinal history as a nontoxic and safe ethnomedicinal herb and has been mentioned in medical papyri to expel fever, relieve headache, inflammation, and to stimulate the central nervous system. *S. chirayita* extracts, did not cause obvious toxic effects in mice as there were no significant differences in body weight and body temperature between the treated and control groups (Alam et al., [@B3]; Das et al., [@B37]). A clinical study by Medda et al. ([@B83]) concluded that *S. chirayita* revealed no evidence of toxicity in both liposomal and niosomal forms. Furthermore, stringent efforts are required to further delineate the well-documented toxicological properties involving toxicity and mutagenic tests to evaluate the safety of this plant. Nevertheless, rigorous clinical studies involving different mechanisms are still needed to confirm the safety of *S. chirayita* in traditional medicine so that it can be used safely and effectively. Despite the fact that the benefits of medicinal plants is globally acknowledged, the need for better insight on the safety evaluation remains essential, so as to differentiate between toxic effects and pharmacological importance of plant extracts (Aremu and Van Staden, [@B8]).

Swertia chirayita conservation {#s6}
==============================

Destruction of plant resources is a normal occurrence. The current speed of extinction through human interferences is estimated to be approximately 100--1000 times faster than the natural speed of extinction (Chapin et al., [@B30]). Due to developmental activities in the Himalayan region, wild populations of many medicinal plants, including *S. chirayita* are reduced to the verge of extinction. *S. chirayita* is traded and used mostly as a traditional drug. Due to its multiple uses the demand is on the rise by both national and international trading leading to increasing over harvesting of wild populations. This has resulted in drastic reductions of its populations. Lack of comprehensive data on annual harvested and traded plants of *S. chirayita* is also a major concern. According to the International Union of Conservation of Nature (IUCN) criteria, *S. chirayita* conservation status has been categorized as "critically endangered" (Joshi and Dhawan, [@B56]). *S. chirayita* is among the 32 most highly prioritized medicinal plants of India as identified by The National Medicinal Plant Board, Government of India (<http://www.nmpb.nic.in>).

The implication of losing this plant species due to extinction lies not only in the loss of genes useful for plant development or in the biosynthesis of new compounds but also the loss of potentially novel compounds of pharmaceutical or nutraceutical benefit. In order to meet the escalating demand in national and international trade markets of raw plants, cultivation must be escalated. There are limitations in the use of seed propagation, due to low viability, and low germination percentages (Badola and Pal, [@B12]; Chandra et al., [@B29]). Biotechnology offers new means of improving biodiversity and biotechnological approaches such as micropropagation techniques (Figure [1E](#F1){ref-type="fig"}) has received more attention and may play a vital role in the establishment of genetically uniform plants for the *Swertia* industry. It is believed that the development of efficient micropropagation protocols, can guarantee an adequate supply of *S. chirayita* plants (devoid of environmental-imposed constraints) with subsequent reduction in uncontrolled harvesting pressure on wild populations. Several studies reported on micropropagation, somatic embryogenesis and acclimatization procedures with the capacity to produce many uniform *S. chirayita* clones throughout the year (Kumar and Chandra, [@B69], [@B70]; Kumar et al., [@B73]). As shown in Table [5](#T5){ref-type="table"}, micropropagation protocols have successfully been established for *S. chirayita* using different explants.

###### 

**Micropropagation data for *Swertia chirayita***.

  **Tissue culture Study**           **Explant type**                      **Optimum concentrations**                              **Major observations**                                                                  **References**
  ---------------------------------- ------------------------------------- ------------------------------------------------------- --------------------------------------------------------------------------------------- ---------------------------
  Regeneration                       Seeds                                 3.0 μM BA                                               Adventitious shoot regeneration from root explants                                      Wawrosch et al., [@B132]
  Micropropagation                   *In vivo* axillary bud/shoot apices   0.5 mg/l BA + 1.0 mg/l GA~3~                            Methods and compositions for rapid *in vitro* propagation                               Ahuja et al., [@B2]
  Axillary multiplication            Seedling-derived nodal explants       4.0 μM BA + 1.5 μM 2iP                                  Improved shoot proliferation                                                            Joshi and Dhawan, [@B57]
  Regeneration                       *In vivo* stem with node              0.44 μM BA + 4.65 μM KN                                 Improved regeneration from the nodal explants                                           Chaudhuri et al., [@B32]
  Direct shoot multiplication        *In vitro* leaves                     2.22 μM BA + 11.6 μM KN + 0.5 μM NAA                    Improved protocol for propagation                                                       Chaudhuri et al., [@B33]
  Regeneration                       Seeds                                 2.22 μM BA + 2.22 μM KN + 0.54 μM NAA                   Regeneration from immature seed culture                                                 Chaudhuri et al., [@B34]
  Direct shoot regeneration          *In vivo* leaves                      13.32 μM BA + 0.54 μM NAA                               *In vitro* shoot regeneration                                                           Wang et al., [@B131]
  Micropropagation                   *In vitro* shoot tip                  1.0 mg/l BA + 0.1 mg/l KN                               Improved shoot proliferation                                                            Balaraju et al., [@B14]
  *In vitro* regeneration            Node                                  2 mg/l BA                                               Rapid *in vitro* propagation system                                                     Koul et al., [@B66]
  Shoot Organogenesis                *In vitro* root                       4.44 μM BA + 1.07 μM NAA                                Improved protocol for plant regeneration                                                Pant et al., [@B93]
  Somatic embryogenesis              *In vivo* leaves                      1.0 mg/l 2,4-D and 0.5 mg/l 2,4-D + 0.5 mg/l BA         Rapid system for micropropagation                                                       Balaraju et al., [@B16]
  Callus culture                     *In vitro* root                       13.32 μM BA + 0.90 μM 2,4-D                             Plant regeneration via indirect organogenesis                                           Pant et al., [@B94]
  Efficient Regeneration             *In vivo* shoot tip                   0.5 mg/l BA + 1.0 mg/l GA~3~                            An efficient shoot proliferation                                                        Kumar and Chandra, [@B69]
  *In vitro* flower production       Axillary bud                          1.0 mg/l BA + 70 mg/l Adenine sulfate                   *In vitro* flowering and effective protocol for regeneration                            Sharma et al., [@B116]
  Somatic embryogenesis              *In vivo* leaves                      0.5 mg/l 2,4-D + 0.5 mg/l KN                            An efficient protocol for plant regeneration through somatic embryogenesis              Kumar and Chandra, [@B70]
  Direct and Indirect regeneration   *In vivo* leaves                      1.0 mg/l BA + 100 mg/l Adenine sulfate + 0.1 mg/l IAA   An efficient protocol of plant regeneration through direct and indirect organogenesis   Kumar et al., [@B73]

2,4-D, 2,4-Dicholorophenoxyacetic acid; BA, 6-benzyl-adenine; GA~3~, Gibberellic acid; IAA, Indole-3-acetic acid; KN, Kinetin; NAA, Naphthalene Acetic Acid.

Synthetic seed technology is also an applied application of modern plant biotechnology which offers tremendous potential for easy handling, micropropagation and plant germplasm conservation through cryopreservation (Ara et al., [@B7]; Sharma et al., [@B114]; Perveen and Anis, [@B98]; Gantait et al., [@B43]). Successful implementation of synthetic seed technology for mass propagation and short-term storage of genetically uniform clones require manipulation of *in vitro* tissue culture systems that are able to transform into complete plantlets (Ara et al., [@B7]). Recently, Kumar et al. ([@B73]) reported on synthetic seed production and plant regeneration of *S. chirayita* from somatic embryos. However, further studies are required to improve technology so that it can be used on a commercial scale.

Many plant secondary metabolites accumulate in roots (Flores et al., [@B42]) but harvesting of these organs is destructive. Therefore, in the recent past *Agrobacterium rhizogenes* induced hairy root technology has received attention and engaged a new platform of applied research in generating pharmaceutical lead compounds. The large scaling-up of hairy root cultures is of importance for biotechnological applications (Guillon et al., [@B49]). Attempts have been made to standardize *A. rhizogenes* transformed root cultures for production of active secondary metabolites under *in vitro* conditions of *S. chirayita* (Keil et al., [@B62]). For commercialization of *S. chirayita* adventitious roots and to elucidate the feasibility for commercial application, hairy root technology is required along with various factors affecting the production of root biomass and bioactive compounds. Overall, micropropagation which is conducted under a controlled environment will help to prevent the current plant biodiversity conservation problems arising from over harvesting practices of wild populations and can profoundly improve the quality of bioactive secondary metabolites of this age old medicinal plant *S. chirayita*.

Conclusions and future perspectives {#s7}
===================================

*S. chirayita* offers many promising prospects for both traditional and modern medicine. *S. chirayita* is apparently a potential herbal therapy for many ailments. This review summarized the existing ethnobotanical uses, phytochemistry, pharmacological activities, safety evaluation, and conservation status on *S. chirayita*.

So far no serious side effects or toxicity of *S. chirayita* have been reported, but further toxicological studies are still needed to confirm the safety of *S. chirayita* in humans. Efforts are required for further studies, especially evaluating its biological activities *in vivo* and toxicological and mutagenic properties in order to better validate the safety of these different plant-derives compounds. In all probability there is a need for clinical trials to establish the efficacy of using *S. chirayita* in medicine. Due to its multiple uses the demand in both national and international markets is constantly on the rise. Overexploitation combined with habitat destruction has resulted in the drastic reduction of its population. For the successful commercialization of this critically endangered medicinal plant any proposed research must be viewed in a wider context that includes conservation practices and sustainable supply of raw plants. This will require innovative tools, which utilize biotechnological interventions, including micropropagation, cryopreservation, and bioreactors for the conservation, as well as for raising commercial production. In synthetic seed technology more detailed research is required mainly for improvement in germination frequency of synthetic seeds and subsequent plantlet growth in soil so that it can be used on a commercial scale. Additionally, in the near future, hairy root technology can be used as a model system and will also provide plant biotechnologists with powerful tools to improve the valuable phytochemicals of *S. chirayita*. Although efficient micropropagation protocols have been established, further studies focusing on seed biology and ways of improving bioactive secondary metabolites in cultivated *S. chirayita* would be beneficial for their commercialization. Quality control protocols to prevent misidentification and possible adulteration of *S. chirayita* are also needed. In summary, *S. chirayita* have been studied extensively in terms of taxonomy, ethnobotany, phytochemistry, biological activities, and conservation. However, new findings may increase the present therapeutic importance of *S. chirayita* and promote their future use in modern medicine, while novel biotechnological approaches are required for further conservation.
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ABTS

:   2,2-azino-bis (3-ethylebenzothiazoline-6-sulphonic acid)

ACE

:   Acetone

BA

:   6-benzyl-adenine

BHA

:   Butylated hydroxy anisole

BHT

:   Butylated hydroxytoluene

2, 4-D

:   2,4-Dicholorophenoxyacetic acid

DPPH

:   2,2-diphenyl-1-picrylhydrazyl

DW

:   Dry weight

EtOH

:   Ethanol

EA

:   Ethyl acetate

FRAP

:   Ferric Reducing Antioxidant Power

GA~3~

:   Gibberellic acid

HEX

:   Hexane

IAA

:   Indole-3-acetic acid

KN

:   Kinetin

MeOH

:   Methanol

NAA

:   Naphthalene Acetic Acid

PE

:   Petroleum ether.
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